Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Satyamitra Kemas Lestari Tbk. (SMKL) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Satyamitra Kemas Lestari Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp141 (market cap 471.7B, 327.2K 24h volume). The key difference: Satyamitra Kemas Lestari Tbk. is far larger — about 2.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Satyamitra Kemas Lestari Tbk. is more actively traded (327.2K versus 218.7K). Which is the better fit depends on your goals.

OBATSMKL
Market Cap
172.82B471.7B
Volume
218.7K327.2K
Lot
2.19K3.27K
Turnover
53.51M45.01M
Average Price
244.66137.57
Value
53.51M45.01M
Indicative Equilibrium Price
252141
Indicative Equilibrium Volume
48392

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
SMKL
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Satyamitra Kemas Lestari Tbk.

PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.

Read more on SMKL